SEC
SlamSEC
Search
Browse
Earnings
Gain Therapeutics, Inc. — SlamSEC
Gain Therapeutics, Inc.
Nasdaq:
GANX
Pharmaceutical Preparations
·
BETHESDA, MD
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Revenue
$55,180
-58.4% YoY
FY 2024
Adj. EBITDA
-$22.2M
-40176.8% margin
FY 2024
Net Income
-$22.3M
-40354.3% margin
FY 2024
EPS (Diluted)
-$1.71
FY 2024
Stock Price
$2.77
-9.3%
2026-03-10
52W Range
$1.41 – $4.34
P/E Ratio
-1.6x
Market Cap
$100.2M
Cash
$11.8M
FY 2024
Total Debt
$449,053
FY 2024
Net Cash
$11.3M
FY 2024
Enterprise Value
$88.8M
Debt / EBITDA
0.5x
FY 2024
EV / EBITDA
-4.0x
Employees
—